Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6099)
All Articles published online
|
Publishing Process of This Article
|
Dec 7, 2014 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Han JH, Kim DG, Na GH, Kim EY, Lee SH, Hong TH, You YK. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma. World J Gastroenterol 2014; 20(45): 17132-17140 [PMID: 25493027 DOI: 10.3748/wjg.v20.i45.17132] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i45/17132.htm |
| Number | Citing Articles |
| 1 |
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, Floriane Sellier, Paul Castellani, Valerie Oules, Herve Perrier, Gaëlle Lefolgoc, Bernard Pol, Manuela Campanile, Olivier Bayle, Patrick Beaurain, Olivier Monnet, Marc Bourlière. Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control study. European Journal of Gastroenterology & Hepatology 2018; 30(4): 368 doi: 10.1097/MEG.0000000000001082
|
| 2 |
Yan Zhou, Lijuan Liu, Youyi Liu, Ping Zhou, Qiujin Yan, Honglian Yu, Xiaobei Chen, Fan Zhu. Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK/ERK-mediated metastatic invasiveness and doxorubicin resistance. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00562-5
|
| 3 |
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World Journal of Gastroenterology 2015; 21(42): 12071-12082 doi: 10.3748/wjg.v21.i42.12071
|
| 4 |
Fu He, Kangjian Song, Ge Guan, Junyu Huo, Yang Xin, Tianxiang Li, Chao Liu, Qingwei Zhu, Ning Fan, Yuan Guo, Liqun Wu. The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine 2021; : 723 doi: 10.2147/PGPM.S313848
|
| 5 |
Chihiro Dohi, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Nozomu Wada, Hideaki Kinugasa, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Fusao Ikeda, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada. Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. Hepatology Research 2016; 46(9): 916 doi: 10.1111/hepr.12636
|
| 6 |
Dongsub Jeon, Won-Mook Choi, Jin-Sun Kim, Yusun Jung, Su-Yeon Lee, Haeng Ran Seo, Kang Mo Kim. Serum Sorbitol Dehydrogenase as a Novel Prognostic Factor for Hepatocellular Carcinoma after Surgical Resection. Cancers 2021; 13(23): 6143 doi: 10.3390/cancers13236143
|
| 7 |
Lisa A. Min, Francesca Castagnoli, Wouter V. Vogel, Jisk P. Vellenga, Joost J.M. van Griethuysen, Max J. Lahaye, Monique Maas, Regina G.H. Beets Tan, Doenja M.J. Lambregts. A decade of multi-modality PET and MR imaging in abdominal oncology. The British Journal of Radiology 2021; 94(1126): 20201351 doi: 10.1259/bjr.20201351
|
| 8 |
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches. Therapeutic Advances in Gastroenterology 2019; 12: 175628481983620 doi: 10.1177/1756284819836205
|
| 9 |
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
|
| 10 |
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
|
| 11 |
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
|
| 12 |
Alastair D Burt, Venâncio Alves, Pierre Bedossa, Andrew Clouston, Maria Guido, Stefan Hübscher, Sanjay Kakar, Irene Ng, Young N Park, Helen Reeves, Judith Wyatt, Matthew M Yeh, David W Ellis. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 2018; 73(3): 369 doi: 10.1111/his.13520
|
| 13 |
René Fahrner, Sandra GC Dennler, Daniel Inderbitzin. Risk of malignancy in Caroli disease and syndrome: A systematic review. World Journal of Gastroenterology 2020; 26(31): 4718-4728 doi: 10.3748/wjg.v26.i31.4718
|
| 14 |
Ningbin Luo, Wenzhu Li, Jisheng Xie, Danhui Fu, Lidong Liu, Xiangyang Huang, Danke Su, Guanqiao Jin. Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection. European Radiology 2021; 31(4): 1872 doi: 10.1007/s00330-020-07330-6
|
| 15 |
Qinqin Liu, Jing Li, Fei Liu, Weilin Yang, Jingjing Ding, Weixia Chen, Yonggang Wei, Bo Li, Lu Zheng. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Cancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00360-9
|
| 16 |
Jun-yi Shen, Chuan Li, Tian-fu Wen, Lv-nan Yan, Bo Li, Wen-tao Wang, Jia-yin Yang, Ming-qing Xu. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. Journal of Surgical Research 2017; 209: 102 doi: 10.1016/j.jss.2016.10.005
|
| 17 |
Tatsuya Orimo, Toshiya Kamiyama, Kenji Wakayama, Shingo Shimada, Akihisa Nagatsu, Yoh Asahi, Yuzuru Sakamoto, Hirofumi Kamachi, Akinobu Taketomi. Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis. Annals of Surgical Oncology 2020; 27(11): 4153 doi: 10.1245/s10434-020-08754-6
|
| 18 |
Lian-Feng Liu, Zhan-Ling Ding, Jian-Hong Zhong, Hong-Xue Li, Jun-Jie Liu, Hang Li, Le-Qun Li. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/8910562
|
| 19 |
Hao Song, Na Ding, Shang Li, Jianlong Liao, Aimin Xie, Youtao Yu, Chunlong Zhang, Caifang Ni. Identification of Hub Genes Associated With Hepatocellular Carcinoma Using Robust Rank Aggregation Combined With Weighted Gene Co-expression Network Analysis. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00895
|
| 20 |
Wenzhi Jia, Qianyun Wu, Xiaofeng Yu, Mengqin Shen, Ruixue Zhang, Jiajin Li, Li Zhao, Gang Huang, Jianjun Liu. Prognostic values of ALDOB expression and 18F-FDG PET/CT in hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1044902
|
| 21 |
Hongfen Wu, Guangcong Zhang, Zhi Li, Jiamei Ma, Xiangyang Han, Tian Xiang, Xuemei Jiang. Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinoma. Gene 2019; 696: 219 doi: 10.1016/j.gene.2019.02.049
|
| 22 |
Teng Zhao, Longjiu Cui, Aijun Li. The significance of RDW in patients with hepatocellular carcinoma after radical resection. Cancer Biomarkers 2016; 16(4): 507 doi: 10.3233/CBM-160591
|
| 23 |
Jin-Chiao Lee, Chih-Hsien Cheng, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee. Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma. Medicine 2019; 98(11): e14827 doi: 10.1097/MD.0000000000014827
|
| 24 |
Jisen Cao, Ruiqiang Zhang, Ye Zhang, Yijun Wang. Risk Factors Affecting the Recurrence-Free Survival of Hepatocellular Carcinoma After Hepatectomy: a Meta-analysis. Indian Journal of Surgery 2022; 84(S2): 373 doi: 10.1007/s12262-022-03287-6
|
| 25 |
Chetana Lim, Chady Salloum, Julia Chalaye, Eylon Lahat, Charlotte E. Costentin, Michael Osseis, Emmanuel Itti, Cyrille Feray, Daniel Azoulay. 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma. HPB 2019; 21(6): 739 doi: 10.1016/j.hpb.2018.10.007
|
| 26 |
Toar J.M. Lalisang, Yefta Moenadjat, Nurjati C. Siregar, Marini Stephanie. Overexpression of p53 in extra large (more than 10 cm) hepatocellular carcinoma. Medical Journal of Indonesia 2018; 27(2) doi: 10.13181/mji.v27i2.1980
|
| 27 |
Shinji Itoh, Tomoharu Yoshizumi, Yoshiyuki Kitamura, Kyohei Yugawa, Norifumi Iseda, Tomonari Shimagaki, Yoshihiro Nagao, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Shingo Baba, Kousei Ishigami, Yoshinao Oda, Masaki Mori. Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation. Hepatology Communications 2021; 5(7): 1278 doi: 10.1002/hep4.1715
|
| 28 |
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis. Abdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9
|